Nefroloji
Synopsis
This section addresses the clinical approaches, pathophysiology, etiologies, complications, diagnosis, and treatment processes of nephrotic and nephritic syndromes occurring as a result of glomerular dysfunction in adults. Nephrotic syndrome is characterized by severe proteinuria (>3.5 g/24h) due to increased capillary permeability, hypoalbuminemia, edema, hyperlipidemia, and lipiduria. It is mostly idiopathic in adults, with minimal change disease, FSGS, and membranous nephropathy among primary causes, while diabetic nephropathy, lupus nephritis, and amyloidosis stand out among secondary causes. Nephritic syndrome presents with hematuria (dysmorphic RBCs/RBC casts), non-nephrotic proteinuria, oliguria, hypertension, and edema resulting from glomerular inflammation. Its etiology includes IgA nephropathy, post-streptococcal GN, SLE, and rapidly progressive GN (RPGN) with crescentic glomerulonephritis. Renal biopsy represents the gold standard for definitive diagnosis in both syndromes. In addition to supportive treatments such as salt/fluid restriction, diuretics, and RAS inhibition (ACEi/ARB), management involves corticosteroids and other immunosuppressive agents (cyclophosphamide, rituximab, calcineurin inhibitors) targeted at the underlying cause. Early recognition, timely nephrology referral, and close monitoring of immunosuppressive side effects are crucial to reducing patient morbidity and mortality.
References
Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, Cook HT, Fervenza FC, Gibson KL, Glassock RJ, Jayne DRW, Jha V, Liew A, Liu ZH, Mejía-Vilet JM, Nester CM, Radhakrishnan J, Rave EM, Reich HN, Ronco P, Sanders JF, Sethi S, Suzuki Y, Tang SCW, Tesar V, Vivarelli M, Wetzels JFM, Lytvyn L, Craig JC, Tunnicliffe DJ, Howell M, Tonelli MA, Cheung M, Earley A, Floege J. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerüler Diseases. Kidney Int. 2021 Oct;100(4):753-779. doi:10.1016/j.kint.2021.05.015. PMID: 34556300.
www.uptodate.com
Temel Nefroloji. Ed. Yeniçerioğlu Y, Güngör Ö, Arıcı M. 2019. Güneş Tıp Kitabevleri.
Kodner C. Diagnosis and Management of Nephrotic Syndrome in Adults. Am Fam Physician. 2016; 93(6):479-85. PMID: 26977832.
Mahalingasivam V, Booth J, Sheaff M, Yaqoob M. Nephrotic syndrome in adults. Acute Med. 2018; 17(1):36-43. PMID: 29589604.
Agrawal S, Zaritsky JJ, Fornoni A, Smoyer WE. Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat Rev Nephrol. 2018; 14(1):57-70. doi: 10.1038/nrneph.2017.155. Epub 2017 Nov 27. Erratum in: Nat Rev Nephrol. 2017; 13;14 (1):70. PMID: 29176657; PMCID: PMC5770189.
Ray EC, Rondon-Berrios H, Boyd CR, Kleyman TR. Sodium retention and volume expansion in nephrotic syndrome: implications for hypertension. Adv Chronic Kidney Dis. 2015; 22(3):179-84. doi: 10.1053/j.ackd.2014.11.006. PMID: 25908466; PMCID: PMC4409655.
Gupta S, Pepper RJ, Ashman N, Walsh SB. Nephrotic Syndrome: Oedema Formation and Its Treatment With Diuretics. Front Physiol. 2019; 15(9):1868. doi: 10.3389/fphys.2018.01868. PMID: 30697163; PMCID: PMC6341062.